Chemomab Therapeutics CMMB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.65 | 12 | -15.90 | -2 | -14.31 | 14 |
| 2025Q3 | 2.63 | 11 | -16.65 | -2 | -14.83 | 12 |
| 2025Q2 | 4.64 | 10 | -20.48 | -2 | -17.18 | 11 |
| 2025Q1 | 4.36 | 10 | -27.77 | -3 | -22.31 | 13 |
| 2024Q4 | 7.24 | 14 | -19.85 | -3 | -15.65 | 17 |
| 2024Q3 | 6.28 | 16 | -26.48 | -3 | -19.66 | 21 |
| 2024Q2 | 3.65 | 10 | -31.15 | -4 | -22.31 | 15 |
| 2024Q1 | 3.12 | 13 | -25.51 | -4 | -19.26 | 18 |
| 2023Q4 | 2.04 | 17 | -3 | 22 | ||
| 2023Q3 | 3.58 | -4 | ||||
| 2023Q2 | 5.26 | 22 | -31.92 | -8 | -24.96 | 29 |
| 2023Q1 | 6.36 | 28 | -27.28 | -9 | -22.42 | 35 |
| 2022Q4 | 12.80 | 36 | -20.46 | -8 | -17.74 | 43 |
| 2022Q3 | 9.96 | 45 | -16.75 | -8 | -15.16 | 50 |
| 2022Q2 | 14.80 | 52 | -11.35 | -6 | -10.55 | 56 |
| 2022Q1 | 19.20 | 57 | -8.60 | -5 | -8.15 | 61 |
| 2021Q4 | 27.60 | 61 | -7.93 | -5 | -7.64 | 64 |
| 2021Q3 | 44.32 | 66 | -4.44 | -3 | -4.30 | 67 |
| 2021Q2 | 76.08 | 68 | -4.50 | -3 | -4.24 | 71 |
| 2021Q1 | 114.84 | 55 | -5.80 | -2 | -5.14 | 60 |